B. Merkel Et Al. , "Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , vol.23, Paris, France, pp.71-73, 2017
Merkel, B. Et Al. 2017. Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 71-73.
Merkel, B., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., ... Izquierdo, G.(2017). Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.71-73). Paris, France
Merkel, B. Et Al. "Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017
Merkel, B. Et Al. "Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.71-73, 2017
Merkel, B. Et Al. (2017) . "Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.71-73.
@conferencepaper{conferencepaper, author={B. Merkel Et Al. }, title={Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={71-73} }